Influence of short-term glucocorticoid therapy on regulatory T cells In Vivo

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Sbiera, Silviu ^a   Dexneit, Thomas ^a   Reichardt, Sybille D ^b   Michel, Kai D ^b   van den Brandt, Jens ^b   Schmull, Sebastian ^a   Kraus, Luitgard ^a   Beyer, Melanie ^a   Mlynski, Robert ^a   Wortmann, Sebastian ^a   Allolio, Bruno ^a   Reichardt, Holger M ^b   Fassnacht, Martin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXA RATIO PHARM; DEXAMETHASONE; PREDNISOLONE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOPHIL; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EOSINOPHIL COUNT; FEMALE; HEARING LOSS; HUMAN; HUMAN CELL; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MALE; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; REGULATORY T LYMPHOCYTE; SHORT COURSE THERAPY; SIDE EFFECT; SPLEEN LYMPHOCYTE; TREATMENT DURATION; ANIMAL; CELL COUNT; CLINICAL TRIAL; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; SPLEEN; TIME;

MUS;

ADULT; ANIMALS; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; SPLEEN; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 80052396066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024345     Document Type: Article

References (69)

1. Norgaard P, Poulsen HS, (1991) Glucocorticoid receptors in human malignancies: a review. Ann Oncol 2: 541-557.
2. Chrousos GP, Kino T, (2009) Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann N Y Acad Sci 1179: 153-166.
3. Zanchi NE, Filho MA, Felitti V, Nicastro H, Lorenzeti FM, et al. (2010) Glucocorticoids: extensive physiological actions modulated through multiple mechanisms of gene regulation. J Cell Physiol 224: 311-315.
4. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, et al. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14: 303-347.
5. Gaillard RC, (2001) Interaction between the hypothalamo-pituitary-adrenal axis and the immunological system. Ann Endocrinol (Paris) 62: 155-163.
6. Da Silva JA, (1999) Sex hormones and glucocorticoids: interactions with the immune system. Ann N Y Acad Sci 876: 102-117; discussion 117-108.
7. Giannopoulos G, (1975) Early events in the action of glucocorticoids in developing tissues. J Steroid Biochem 6: 623-631.
8. Martignoni E, Costa A, Sinforiani E, Liuzzi A, Chiodini P, et al. (1992) The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology 17: 343-354.
9. Franchimont D, (2004) Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann N Y Acad Sci 1024: 124-137.
10. Cox G, (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 154: 4719-4725.
11. Nakagawa M, Bondy GP, Waisman D, Minshall D, Hogg JC, et al. (1999) The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte. Blood 93: 2730-2737.
12. Schleimer RP, Bochner BS, (1994) The effects of glucocorticoids on human eosinophils. J ALLERGY CLIN IMMUNOL 94: 1202-1213.
13. Yoshimura C, Miyamasu M, Nagase H, Iikura M, Yamaguchi M, et al. (2001) Glucocorticoids induce basophil apoptosis. J ALLERGY CLIN IMMUNOL 108: 215-220.
14. van der Goes A, Hoekstra K, van den Berg TK, Dijkstra CD, (2000) Dexamethasone promotes phagocytosis and bacterial killing by human monocytes/macrophages in vitro. J Leukoc Biol 67: 801-807.
15. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, et al. (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. Faseb J 16: 61-71.
16. Cupps TR, Edgar LC, Thomas CA, Fauci AS, (1984) Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. J Immunol 132: 170-175.
17. Segerer SE, Muller N, van den Brandt J, Kapp M, Dietl J, et al. (2009) Impact of female sex hormones on the maturation and function of human dendritic cells. Am J Reprod Immunol 62: 165-173.
18. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, et al. (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195: 603-616.
19. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
20. Jacobson DL, Gange SJ, Rose NR, Graham NM, (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84: 223-243.
21. Sakaguchi S, (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455-458.
22. Hahn K, Husstedt IW, (2010) [HIV-associated neuropathies]. Nervenarzt 81: 409-417.
23. Vucic S, Kiernan MC, Cornblath DR, (2009) Guillain-Barre syndrome: an update. J Clin Neurosci 16: 733-741.
24. Kondelkova K, Vokurkova D, Krejsek J, Borska L, Fiala Z, et al. (2010) Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Medica (Hradec Kralove) 53: 73-77.
25. Sojka DK, Huang YH, Fowell DJ, (2008) Mechanisms of regulatory T-cell suppression- a diverse arsenal for a moving target. Immunology 124: 13-22.
26. Hench P, (1950) Effects of cortisone in the rheumatic diseases. Lancet 2: 483-484.
27. Hirschberg T, Randazzo B, Hirschberg H, (1980) Effects of methylprednisolone on the in vitro induction and function of suppressor cells in man. Scand J Immunol 12: 33-39.
28. Ikeda T, Uchihara M, Daiguji Y, Hasumura Y, Takeuchi J, (1988) Immunological mechanisms of corticosteroid therapy in chronic active hepatitis: analysis of peripheral blood suppressor T-cell and interleukin 2 activities. Clin Immunol Immunopathol 48: 371-379.
29. Damoiseaux J, (2006) Regulatory T cells: back to the future. Neth J Med 64: 4-9.
30. McNeill A, Spittle E, Backstrom BT, (2007) Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand J Immunol 65: 63-69.
31. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, et al. (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192: 303-310.
32. Read S, Malmstrom V, Powrie F, (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192: 295-302.
33. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, et al. (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
34. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
35. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
36. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
37. Wieckiewicz J, Goto R, Wood KJ, (2010) T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol 22: 662-668.
38. Hori S, (2010) Developmental plasticity of Foxp3+ regulatory T cells. Curr Opin Immunol 22: 575-582.
39. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, et al. (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114: 1425-1433.
40. Chen X, Murakami T, Oppenheim JJ, Howard OM, (2004) Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol 34: 859-869.
41. Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Howard OM, (2006) Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol 36: 2139-2149.
42. Stock P, Akbari O, DeKruyff RH, Umetsu DT, (2005) Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol 175: 7380-7387.
43. Wust S, van den Brandt J, Tischner D, Kleiman A, Tuckermann JP, et al. (2008) Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol 180: 8434-8443.
44. Azab NA, Bassyouni IH, Emad Y, Abd El-Wahab GA, Hamdy G, et al. (2008) CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 127: 151-157.
45. Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, et al. (2008) Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 47: 789-794.
46. Suarez A, Lopez P, Gomez J, Gutierrez C, (2006) Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 65: 1512-1517.
47. Provoost S, Maes T, van Durme YM, Gevaert P, Bachert C, et al. (2009) Decreased FOXP3 protein expression in patients with asthma. Allergy 64: 1539-1546.
48. Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, et al. (2006) Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 116: 146-155.
49. Zhang Q, Qian FH, Liu H, Zhou LF, Huang M, et al. (2008) Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid. Chin Med J (Engl) 121: 205-212.
50. Braitch M, Harikrishnan S, Robins RA, Nichols C, Fahey AJ, et al. (2009) Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol Scand 119: 239-245.
51. Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, et al. (2005) Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 116: 134-141.
52. Ling Y, Cao X, Yu Z, Ruan C, (2007) Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol 79: 310-316.
53. Xu L, Xu Z, Xu M, (2009) Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis. Clin Exp Immunol 158: 26-30.
54. Zhu YF, Cai XH, Zhu JY, Jiang WP, Lan JH, et al. (2009) [Study of CD4+ CD25+ regulatory T cells and expression of Foxp3 mRNA in bronchiolitis and glucocorticoid regulation]. Zhonghua Yi Xue Za Zhi 89: 1563-1566.
55. Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, et al. (2009) Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42: 41-49.
56. Majak P, Rychlik B, Stelmach I, (2009) The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clin Exp Allergy 39: 1830-1841.
57. Zhang B, Zhang X, Tang F, Zhu L, Liu Y, (2008) Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol 153: 182-187.
58. Xiang L, Marshall GD Jr, (2010) Immunomodulatory Effects of in vitroStress Hormones on FoxP3, Th1/Th2 Cytokine and Costimulatory Molecule mRNA Expression in Human Peripheral Blood Mononuclear Cells. Neuroimmunomodulation 18: 1-10.
59. Fassnacht M, Lee J, Milazzo C, Boczkowski D, Su Z, et al. (2005) Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy. Clin Cancer Res 11: 5566-5571.
60. Milligan NM, Newcombe R, Compston DA, (1987) A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry 50: 511-516.
61. Noseworthy JH, (2003) Management of multiple sclerosis: current trials and future options. Curr Opin Neurol 16: 289-297.
62. Wust S, Tischner D, John M, Tuckermann JP, Menzfeld C, et al. (2009) Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. PLoS One 4: e8202.
63. Xie Y, Wu M, Song R, Ma J, Shi Y, et al. (2009) A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation. Acta Biochim Biophys Sin (Shanghai) 41: 781-791.
64. Matyszak MK, Citterio S, Rescigno M, Ricciardi-Castagnoli P, (2000) Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 30: 1233-1242.
65. Crane J, Pearce N, Burgess C, Woodman K, Robson B, et al. (1992) Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 21: 737-744.
66. Wei BP, Mubiru S, O'Leary S, (2006) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev.
67. Conlin AE, Parnes LS, (2007) Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 133: 582-586.
68. Viertel A, Weidmann E, Wigand R, Geiger H, Mondorf UF, (2000) Treatment of severe systemic lupus erythematosus with immunoadsorption and intravenous immunoglobulins. Intensive Care Med 26: 823-824.
69. Cines DB, Bussel JB, (2005) How I treat idiopathic thrombocytopenic purpura (ITP). Blood 106: 2244-2251.